Correlation Engine 2.0
Clear Search sequence regions


  • ADAM10 (1)
  • alpha7 nAChR (1)
  • amyloid (3)
  • APP (7)
  • benzamides (2)
  • bicyclo compounds (2)
  • Chrna7 (1)
  • control group (1)
  • factor (2)
  • heme (2)
  • hippocampus (1)
  • Hmox1 protein (1)
  • memory (4)
  • mice (8)
  • nAChR (4)
  • NF E2 (2)
  • nfe2l2 protein (1)
  • Nrf2 (3)
  • pnu 282987 (2)
  • presenilin 1 (3)
  • protein precursor (2)
  • receptor (1)
  • signal (1)
  • Sizes of these terms reflect their relevance to your search.

    BACKGROUND To reveal the mechanism underlying the effect of alpha7 nicotinic acetylcholine receptor (nAChR) on neurodegeneration in Alzheimer disease (AD), the influence of the receptor on recognition in APP/PS1 mice was evaluated by using its selective agonist (PNU-282987). MATERIAL AND METHODS APP/PS1 and wild-type (WT) mice were treated with PNU or saline, respectively, for 7 days at the ages of 6 and 10 months. RESULTS Morris water maze analysis showed that both at 6 and 10 months of age, PNU treatment enhanced the learning and memory of APP/PS1 mice. However, PNU treatment did not alter the number of senile plaques. Furthermore, a higher protein expression of Nrf2/HO-1, ADAM10, SYP, and SNAP-25, and a lower level of oxidative stress, were observed in the hippocampus of APP/PS1 mice treated with PNU compared with the control group. CONCLUSIONS The results indicated that the activation of alpha7 nAChR by PNU improved the learning and memory of mice carrying the APP/PS1 mutation, regulated the levels of enzymes that mediate APP metabolization to reduce ß-amyloid peptide damage, and decreased the level of oxidative stress and maintained synaptic plasticity, in which the mechanism might be enhancement of the Nrf2/HO-1 pathway.

    Citation

    Kun Cao, Jie Xiang, Yang-Ting Dong, Yi Xu, Zhi-Zhong Guan. Activation of α7 Nicotinic Acetylcholine Receptor by its Selective Agonist Improved Learning and Memory of Amyloid Precursor Protein/Presenilin 1 (APP/PS1) Mice via the Nrf2/HO-1 Pathway. Medical science monitor : international medical journal of experimental and clinical research. 2022 Jan 04;28:e933978

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 34980874

    View Full Text